Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1971 1
1972 1
1979 1
1981 2
1983 1
1984 4
1985 4
1986 5
1987 2
1988 2
1989 3
1990 1
1991 2
1992 2
1993 1
1994 4
1995 3
1996 3
1997 2
1998 6
1999 6
2000 8
2001 1
2002 8
2003 8
2004 10
2005 7
2006 19
2007 11
2008 4
2009 9
2010 9
2011 14
2012 13
2013 9
2014 8
2015 6
2016 3
2017 9
2018 12
2019 13
2020 7
2021 11
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

238 results
Results by year
Filters applied: . Clear all
Page 1
A phase 3 trial of bevacizumab in ovarian cancer.
Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Kurzeder C, du Bois A, Sehouli J, Kimmig R, Stähle A, Collinson F, Essapen S, Gourley C, Lortholary A, Selle F, Mirza MR, Leminen A, Plante M, Stark D, Qian W, Parmar MK, Oza AM; ICON7 Investigators. Perren TJ, et al. Among authors: beale p. N Engl J Med. 2011 Dec 29;365(26):2484-96. doi: 10.1056/NEJMoa1103799. N Engl J Med. 2011. PMID: 22204725 Free article. Clinical Trial.
Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
Berton-Rigaud D, Devouassoux-Shisheboran M, Ledermann JA, Leitao MM, Powell MA, Poveda A, Beale P, Glasspool RM, Creutzberg CL, Harter P, Kim JW, Reed NS, Ray-Coquard I. Berton-Rigaud D, et al. Among authors: beale p. Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S55-60. doi: 10.1097/IGC.0000000000000228. Int J Gynecol Cancer. 2014. PMID: 25341582 Review.
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
Oza AM, Cook AD, Pfisterer J, Embleton A, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Park-Simon TW, Rustin G, Joly F, Mirza MR, Plante M, Quinn M, Poveda A, Jayson GC, Stark D, Swart AM, Farrelly L, Kaplan R, Parmar MK, Perren TJ; ICON7 trial investigators. Oza AM, et al. Among authors: beale p. Lancet Oncol. 2015 Aug;16(8):928-36. doi: 10.1016/S1470-2045(15)00086-8. Epub 2015 Jun 23. Lancet Oncol. 2015. PMID: 26115797 Free PMC article. Clinical Trial.
Obituaries.
Beale P. Beale P. BMJ. 2000 Jun 17;320(7250):1673. BMJ. 2000. PMID: 10856077 Free PMC article. No abstract available.
Thymidylate synthase inhibitors.
Ackland SP, Beale P, Peters GJ. Ackland SP, et al. Among authors: beale p. Cancer Chemother Biol Response Modif. 2003;21:1-28. doi: 10.1016/s0921-4410(03)21001-2. Cancer Chemother Biol Response Modif. 2003. PMID: 15338738 Review. No abstract available.
Clinical trials in recurrent ovarian cancer.
Friedlander M, Trimble E, Tinker A, Alberts D, Avall-Lundqvist E, Brady M, Harter P, Pignata S, Pujade-Lauraine E, Sehouli J, Vergote I, Beale P, Bekkers R, Calvert P, Copeland L, Glasspool R, Gonzalez-Martin A, Katsaros D, Kim JW, Miller B, Provencher D, Rubinstein L, Atri M, Zeimet A, Bacon M, Kitchener H, Stuart GC; Gynecologic Cancer InterGroup. Friedlander M, et al. Among authors: beale p. Int J Gynecol Cancer. 2011 May;21(4):771-5. doi: 10.1097/IGC.0b013e31821bb8aa. Int J Gynecol Cancer. 2011. PMID: 21543939 Review.
Applications of S-layers.
Sleytr UB, Bayley H, Sára M, Breitwieser A, Küpcü S, Mader C, Weigert S, Unger FM, Messner P, Jahn-Schmid B, Schuster B, Pum D, Douglas K, Clark NA, Moore JT, Winningham TA, Levy S, Frithsen I, Pankovc J, Beale P, Gillis HP, Choutov DA, Martin KP. Sleytr UB, et al. Among authors: beale p. FEMS Microbiol Rev. 1997 Jun;20(1-2):151-75. doi: 10.1111/j.1574-6976.1997.tb00306.x. FEMS Microbiol Rev. 1997. PMID: 9276930 Free article. Review.
238 results